133 related articles for article (PubMed ID: 14871986)
1. Genetic pathways and new progression markers for prostate cancer suggested by microsatellite allelotyping.
von Knobloch R; Konrad L; Barth PJ; Brandt H; Wille S; Heidenreich A; Moll R; Hofmann R
Clin Cancer Res; 2004 Feb; 10(3):1064-73. PubMed ID: 14871986
[TBL] [Abstract][Full Text] [Related]
2. Differential chromosome allelic imbalance in the progression of human prostate cancer.
Latil A; Fournier G; Cussenot O; Lidereau R
J Urol; 1996 Dec; 156(6):2079-83. PubMed ID: 8911394
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
[TBL] [Abstract][Full Text] [Related]
4. Genetic pattern of prostate cancer progression.
Saric T; Brkanac Z; Troyer DA; Padalecki SS; Sarosdy M; Williams K; Abadesco L; Leach RJ; O'Connell P
Int J Cancer; 1999 Apr; 81(2):219-24. PubMed ID: 10188722
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
[TBL] [Abstract][Full Text] [Related]
6. Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients.
Beau-Faller M; Gaub MP; Schneider A; Ducrocq X; Massard G; Gasser B; Chenard MP; Kessler R; Anker P; Stroun M; Weitzenblum E; Pauli G; Wihlm JM; Quoix E; Oudet P
Int J Cancer; 2003 Jun; 105(3):361-70. PubMed ID: 12704670
[TBL] [Abstract][Full Text] [Related]
7. Allelic imbalance in hereditary and sporadic prostate cancer.
Verhage BA; van Houwelingen K; Ruijter TE; Kiemeney LA; Schalken JA
Prostate; 2003 Jan; 54(1):50-7. PubMed ID: 12481255
[TBL] [Abstract][Full Text] [Related]
8. Pathways of urothelial cancer progression suggested by Bayesian network analysis of allelotyping data.
Bulashevska S; Szakacs O; Brors B; Eils R; Kovacs G
Int J Cancer; 2004 Jul; 110(6):850-6. PubMed ID: 15170667
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance-promising for molecular staging of prostate cancers.
Bryś M; Migdalska-Sęk M; Pastuszak-Lewandoska D; Forma E; Czarnecka K; Domańska D; Nawrot E; Wilkosz J; Różański W; Brzeziańska E
Med Oncol; 2013 Mar; 30(1):391. PubMed ID: 23288724
[TBL] [Abstract][Full Text] [Related]
10. Genetic pathways and new progression markers for prostate cancer defined by microsatellite allelotyping.
von Knobloch R; Konrad L; Barth PJ; Brandt H; Wille S; Heidenreich A; Moll R; Hofmann R
Urologe A; 2004 Sep; 43 Suppl 3():S149-52. PubMed ID: 15241597
[TBL] [Abstract][Full Text] [Related]
11. Molecular serological diagnosis in transitional cell bladder cancer.
von Knobloch R; Brandt H; Hofmann R
Ann N Y Acad Sci; 2004 Jun; 1022():70-5. PubMed ID: 15251942
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
[TBL] [Abstract][Full Text] [Related]
13. Identification of two distinct regions of allelic imbalance on chromosome 18Q in metastatic prostate cancer.
Padalecki SS; Troyer DA; Hansen MF; Saric T; Schneider BG; O'Connell P; Leach RJ
Int J Cancer; 2000 Mar; 85(5):654-8. PubMed ID: 10699945
[TBL] [Abstract][Full Text] [Related]
14. Molecular serological detection of DNA alterations in transitional cell carcinoma is highly sensitive and stage independent.
von Knobloch R; Brandt H; Schrader AJ; Heidenreich A; Hofmann R
Clin Cancer Res; 2004 Feb; 10(3):988-93. PubMed ID: 14871977
[TBL] [Abstract][Full Text] [Related]
15. Identification of genetic markers for prostatic cancer progression.
Alers JC; Rochat J; Krijtenburg PJ; Hop WC; Kranse R; Rosenberg C; Tanke HJ; Schröder FH; van Dekken H
Lab Invest; 2000 Jun; 80(6):931-42. PubMed ID: 10879743
[TBL] [Abstract][Full Text] [Related]
16. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.
Cunningham JM; Shan A; Wick MJ; McDonnell SK; Schaid DJ; Tester DJ; Qian J; Takahashi S; Jenkins RB; Bostwick DG; Thibodeau SN
Cancer Res; 1996 Oct; 56(19):4475-82. PubMed ID: 8813143
[TBL] [Abstract][Full Text] [Related]
17. Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.
Erbersdobler A; Friedrich MG; Schwaibold H; Henke RP; Huland H
Oncol Res; 1998; 10(8):415-20. PubMed ID: 10100758
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder.
Chang HJ; Kim SW; Kim YT; Kim WH
Mod Pathol; 1999 Aug; 12(8):763-9. PubMed ID: 10463477
[TBL] [Abstract][Full Text] [Related]
19. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
[TBL] [Abstract][Full Text] [Related]
20. [Frequent allelic losses in tumor-associated stromal cells and tumor epitelium of prostate cancer].
Kekeeva TV; Popova OP; Shegaĭ PV; Zavalishina LE; Andreeva IuIu; Zaletaev DV; Nemtsova MV
Mol Biol (Mosk); 2008; 42(1):96-101. PubMed ID: 18389625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
